Improvement of chronic allograft nephropathy by reduction of calcineurin inhibitor and introduction of mycophenolic acid

被引：0
|
作者：
Merkel, Saskia [1 ]
Mengel, Michael [2 ]
Haller, Hermann [1 ]
Schwarz, Anke [1 ]
机构：
[1] Sch Med, Dept Nephrol, Hannover, Germany
[2] Sch Med, Dept Pathol, Hannover, Germany
来源：
TRANSPLANT INTERNATIONAL | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [31] Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?
    Lai, WJ
    Chiang, YJ
    Chen, Y
    Chu, SH
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2056 - 2057
  • [32] Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients
    Larissa Kerecuk
    Judy Taylor
    Godfrey Clark
    Pediatric Nephrology, 2005, 20 : 1630 - 1635
  • [33] Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients
    Kerecuk, L
    Taylor, J
    Clark, G
    PEDIATRIC NEPHROLOGY, 2005, 20 (11) : 1630 - 1635
  • [34] Conversion to sirolimus from a calcineurin inhibitor based protocol does not worsen proteinuria or glomerular permeability to macromolecules in patients with chronic allograft nephropathy.
    Guasch, Antonio
    Barakat, Iyad
    Near, Mitzi
    Selvaraj, Sasi
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 441 - 441
  • [35] Is TH17 associated with chronic calcineurin inhibitor toxicity in renal allograft recipients?
    Prasad, Narayan
    Yadav, Brijesh
    Agarwal, Vikas
    Agarwal, Vinita
    Sharma, R. K.
    TRANSPLANTATION, 2016, 100 (07) : S225 - S226
  • [36] Glomerular Abnormalities Associated with Chronic Calcineurin Inhibitor Nephrotoxicity in Late Renal Allograft Biopsies
    Toki, Daisuke
    Okumi, Masayoshi
    Inui, Masashi
    Shimizu, Tomokazu
    Omoto, Kazuya
    Unagami, Kohei
    Ishida, Hideki
    Kondo, Tsunenori
    Tanabe, Kazunari
    TRANSPLANTATION, 2018, 102 : S490 - S490
  • [37] Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant
    Meaney, Calvin J.
    Sudchada, Patcharaporn
    Consiglio, Joseph D.
    Wilding, Gregory E.
    Cooper, Louise M.
    Venuto, Rocco C.
    Tornatore, Kathleen M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (10): : 1351 - 1365
  • [38] CALCINEURIN-INHIBITOR-FREE THERAPIE WITH EVEROLIMUS AND MYCOPHENOLIC-ACID IN CARDIAC TRANSPLANT RECIPIENTS WITH CHRONIC KIDNEY DISEASE: EARLY FOLLOW UP
    Fuchs, U.
    Zittermann, A.
    Schulze, B.
    Deyerling, W.
    Hakim-Meibodi, K.
    Schulz, U.
    Gummert, J.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 23 - 24
  • [39] Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil
    McKane, W
    Kanganas, C
    Preston, R
    Cairns, T
    Hakim, N
    Palmer, A
    Taube, D
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1224 - 1225
  • [40] Calcineurin inhibitors and proximal renal tubular injury in renal transplant patients with proteinuria and chronic allograft nephropathy
    Bone, JM
    Amara, AB
    Shenkin, A
    Hammad, A
    Seffis, RA
    Alexander, JL
    McArdle, F
    Rustom, R
    TRANSPLANTATION, 2005, 79 (01) : 119 - 122
12345